Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tara L. Kaufmann
Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights From Real‐World Practice
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Checkpoint Inhibitor Pneumonitis — Real-World Incidence and Risk
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Combination VEGFR/immune Checkpoint Inhibitor Therapy: A Promising New Treatment for Renal Cell Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Salvage Systemic Therapy for Advanced Urothelial Carcinoma: On the Cusp of a Sea Change?
Oncologist
Cancer Research
Medicine
Oncology
T-Cell Lymphoma Secondary to Checkpoint Inhibitor Therapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy
Clinical Cancer Research
Cancer Research
Oncology
Trends in the Utilization of Imaging for Upper Tract Urothelial Carcinoma
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy
Clinical Genitourinary Cancer
Oncology
Urology
Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Real-World Clinical Outcomes of Pazopanib Immediately Following Immunotherapy Discontinuation for the Treatment of Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology